These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8333228)

  • 21. Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator.
    Hong TT; Driscoll EM; White AJ; Sherigill A; Giboulot TA; Lucchesi BR
    J Pharmacol Exp Ther; 2003 Aug; 306(2):616-23. PubMed ID: 12734394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The acute coronary ischemic syndromes--the central role of thrombosis.
    Cairns JA
    Can J Cardiol; 1996 Oct; 12(10):901-7. PubMed ID: 9191478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction.
    Fuster V; Stein B; Badimon L; Chesebro JH
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):78A-84A. PubMed ID: 3057038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis.
    Agnelli G
    Cardiovasc Res; 1996 Feb; 31(2):232-4. PubMed ID: 8730398
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reocclusion following successful thrombolysis. Emerging concepts.
    Becker RC
    Cardiology; 1993; 82(4):265-73. PubMed ID: 8402753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of action of thrombin inhibitors.
    Bates SM; Weitz JI
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():27F-32. PubMed ID: 11156731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombolysis in acute myocardial infarct of embolic origin].
    Meléndez HR; Leiva Pons JL; Simón S; Céspedes F; Peña Duque MA
    Arch Inst Cardiol Mex; 1996; 66(2):122-8. PubMed ID: 8768629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis, anticoagulation, and reocclusion.
    Rapaport E
    Am J Cardiol; 1991 Dec; 68(16):17E-22E. PubMed ID: 1746447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion.
    Becker RC
    Clin Cardiol; 1994 Jan; 17(1):3-13. PubMed ID: 8149679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rethrombosis after coronary thrombolysis].
    Li TD
    Zhonghua Nei Ke Za Zhi; 1992 Apr; 31(4):246-8. PubMed ID: 1425006
    [No Abstract]   [Full Text] [Related]  

  • 34. New approaches to treatment of myocardial infarction.
    Chesebro JH; Badimon L; Fuster V
    Am J Cardiol; 1990 Feb; 65(6):12C-19C. PubMed ID: 2405621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early reocclusion after successful thrombolysis is related to lesion length and roughness.
    de Cesare NB; Ellis SG; Williamson PR; Deboe SF; Pitt B; Mancini GB
    Coron Artery Dis; 1993 Feb; 4(2):159-66. PubMed ID: 8269207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet and anticoagulant use after myocardial infarction.
    Almony GT; Lefkovits J; Topol EJ
    Clin Cardiol; 1996 May; 19(5):357-65. PubMed ID: 8723593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laboratory monitoring of thrombolytic therapy in clinical practice and research].
    Grünewald M; Seifried E
    Z Kardiol; 1993; 82 Suppl 2():129-35. PubMed ID: 8328190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reocclusion after thrombolysis in acute myocardial infarct. Physiopathological mechanisms and prevention].
    Fornaro G; Aina F; Prando MD; Rossi L; Dellavesa P; Cernigliaro C
    G Ital Cardiol; 1994 Jul; 24(7):887-900. PubMed ID: 7926387
    [No Abstract]   [Full Text] [Related]  

  • 39. Limitations of currently available thrombolytic therapy.
    Otaal PS; Talwar KK
    Indian Heart J; 2009; 61(5):470-5. PubMed ID: 20635766
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of new anticoagulants as adjunctive therapy during thrombolysis.
    Eisenberg PR
    Am J Cardiol; 1991 Jan; 67(3):19A-24A. PubMed ID: 1990782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.